新诊断认知障碍的结构性脑影像检查:按Medicare覆盖类型分析
本研究基于2020至2022年全美Medicare数据,纳入2021年新诊断认知障碍的65至84岁社区居住受益人1,095,947例,其中轻度认知障碍(MCI)373,561例(34.1%),痴呆722,386例(65.9%)。结果显示,诊断前后365天内结构影像(MRI或CT)总体使用率为56.6%,痴呆初诊为65.9%,MCI为50.5%。非双重资格者使用率高于双重资格者,传统Medicare高于Medicare Advantage,且MRI使用率仅29.3%。结论认为结构影像使用不足,在Medicare Advantage成员和社会经济弱势的双重资格者中更为突出。
要点
- 新诊断认知障碍后365天内结构影像总体使用率仅56.6%,指南推荐执行不足。
- 痴呆初诊影像使用率(65.9%)高于MCI(50.5%),MRI仅占29.3%。
- Medicare Advantage成员及双重资格者影像使用率更低,存在公平性差距。
核心结论
- 在2021年全美新诊断认知障碍的Medicare人群中,结构性脑影像检查使用明显不足。
- 这种适当医疗的差距在Medicare Advantage计划成员和社会经济弱势的双重资格者中更为突出。
- 需要持续努力确保公平地遵循指南推荐的结构影像检查。
研究设计与样本
- 横断面研究,使用2020至2022年传统Medicare和Medicare Advantage的100%数据。
- 纳入2021年新诊断认知障碍的65至84岁社区居住Medicare受益人共1,095,947例。
- 参考标准为诊断前后365天内接受MRI或CT结构影像检查。
诊断标准与关键数值
- 总体影像使用率(诊断前后365天内MRI或CT)为56.6%。
- 痴呆初诊影像使用率为65.9%,MCI初诊为50.5%。
- 传统Medicare中非双重资格者使用率60.5%,双重资格者57.9%;Medicare Advantage中非双重资格者54.35%,双重资格者52.7%。
- 初次扫描采用MRI的比例为29.3%,双重资格者和Medicare Advantage成员中更低。
临床应用与阅片要点
- 对认知障碍新诊断患者,应关注是否在诊断前后365天内完成结构影像检查。
- 报告时需注意MRI使用率偏低,可结合指南推荐提示临床优先选择MRI。
- 关注Medicare Advantage及双重资格患者群体,避免因覆盖类型差异导致检查不足。
局限性
- 横断面设计无法推断因果关系。
- 仅纳入65至84岁社区居住受益人,未覆盖更年轻或机构居住人群。
- 未报告影像结果与临床结局的关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Structural brain imaging is guideline-recommended for cases with newly diagnosed cognitive impairment. Adherence to this recommendation and differences by Medicare coverage type are not known. We determined the structural imaging rate overall and by Medicare coverage type: traditional Medicare, Medicare Advantage, and dual eligibility for Medicare and Medicaid ("duals") and diagnosis of mild cognitive impairment (MCI) and dementia.
METHODS: In this cross-sectional study, we used the 100% data for traditional Medicare and Medicare Advantage from 2020 through 2022. A total of 1,095,947 community-dwelling Medicare beneficiaries aged 65 to 84 were newly diagnosed with cognitive impairment in 2021, 373,561 (34.1%) with MCI and 722,386 (65.9%) with dementia. We determined receipt of structural imaging with MRI or CT scan within 365 days before or after the diagnosis.
RESULTS: Overall imaging rates within 365 days of diagnosis were 56.6% overall and 65.9% and 50.5% for an initial diagnosis of dementia and MCI, respectively. Rates were higher for nonduals than duals in traditional Medicare (60.5% versus 57.9%) and members of Medicare Advantage Plans (54.35 versus 52.7%). The initial scan was performed with an MRI in 29.3% of cases with lower rates in duals and Medicare Advantage.
CONCLUSIONS: In the 2021 full Medicare population with a new diagnosis of cognitive impairment, structural brain imaging was substantially underused. This gap in appropriate care was accentuated in Medicare Advantage Plan members and the socioeconomically disadvantaged duals. Sustained efforts are needed to ensure equitable adherence to this guideline-recommended procedure.
SUMMARY: This observational study of the full Medicare population shows that structural brain imaging after diagnosis of cognitive impairment is underused, with lower rates in Medicare Advantage and for duals.
引用
- Mattke S, Liu Y, Ye W, et al. Structural Brain Imaging for Newly Diagnosed Cognitive Impairment by Medicare Coverage Type. J Am Coll Radiol. 2026. PMID: 42744196. doi:10.1016/j.jacr.2026.09.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。